MRK
Merck & Co Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of whom it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada.
Market Cap: 313 Billion
Primary Exchange: NEW YORK STOCK EXCHANGE INC.
Website: https://www.merck.com/
Shares Outstanding: 2.53 Billion
Float: 0
Dividend: 2.9296640548510138 (0.02%)
Beta: 0.3208878231728113
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Ethical Flags
Longest drawdown: 734 trading days
From: 2020-01-02 To: 2022-05-13
Lowest Point:
FDA names companies to build blockchain network for drug supply chain
via: SeekingAlpha at 2019-06-13 04:20:52:000
The FDA has selected IBM (NYSE: IBM ), KPMG International, Merck (NYSE: MRK ) and Walmart (NYSE: WMT ) for a program to support the U.S. Drug Supply Chain Security Act (DSCSA). More news on: International Business Machines Corporation, Merck & Co., Inc., Walmart Inc., Healthcare stocks… read more...
IBM, KPMG, Merck and Walmart to collaborate as part of FDA's program to evaluate the use of blockchain to protect pharmaceutical product integrity
via: PR Newswire at 2019-06-13 04:05:00:000
ARMONK, N.Y. , NEW YORK , KENILWORTH, N.J. , and BENTONVILLE, Ark. , June 13, 2019 /PRNewswire/ --IBM (NYSE: IBM ), KPMG, Merck (NYSE: MRK), and Walmart (NYSE: WMT)today announced that the companies have been selected by the United States Food and Drug Administration (FDA)… read more...
Key events next week - healthcare
via: SeekingAlpha at 2019-06-13 03:28:10:000
Noteworthy events during the week of June 16 - 22 for healthcare investors. More news on: ProMIS Neurosciences, Inc., Merck & Co., Inc., IQVIA Holdings Inc., Healthcare stocks news, , Read more … read more...
Healthcare Stocks: Invest In Business, Not Science
via: SeekingAlpha at 2019-06-13 02:35:46:000
By Vinay Thapar Healthcare stocks served as powerful painkillers during last year's market declines. Yet the sector offers much more than just downside protection for investors who focus on business potential and resist the urge to predict scientific breakthroughs. While the MSCI World I… read more...
Merck Makes Bold Acquisition, Which If It Succeeds Could End Up Paying Off
via: SeekingAlpha at 2019-06-12 13:21:17:000
Merck ( MRK ) announced that it had entered into an agreement to acquire Tilos Therapeutics . This is a good deal for Merck because it will give it an opportunity to test its drug Keytruda in combination with Tilos' anti-LAP antibodies to treat patients with cancer. The promise of this early … read more...
BIIB Is For Buy-O-Gen
via: SeekingAlpha at 2019-06-12 06:30:36:000
Let's spell Biogen Buy-o-Gen. Indeed, BIIB seems increasingly appealing at current price. The biotech focuses on discovering, developing, and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets various products for multiple sc… read more...
IMV's DPX-Survivac shows encouraging action in mid-stage DLBCL study
via: SeekingAlpha at 2019-06-12 03:45:16:000
Updated results from a Phase 2 clinical trial, SPiReL , evaluating IMV's (NASDAQ: IMV ) lead candidate DPX-Survivac, combined with low-dose cyclophosphamide and Merck's (NYSE: MRK ) Keytruda (pembrolizumab), in patients with persistent or relapsed/refractory diffuse large B-cell lymphoma… read more...
Merck And Private Partner NGM Hope For Once-Monthly Dosing NASH Drug
via: SeekingAlpha at 2019-06-11 15:33:43:000
Merck (MRK) and its partner NGM Biopharmaceuticals hope to deliver on a potential treatment for non-alcoholic steatohepatitis and type 2 diabetes. This is what both companies showed when some preliminary data was released for a study using MK-3655 to treat patients with non-alcoholic fatty l… read more...
Iovance Makes Significant Impact At ASCO 2019 Conference With Cancer Drug
via: SeekingAlpha at 2019-06-11 10:52:56:000
Iovance Biotherapeutics ( IOVA ) had made a very large impact at ASCO 2019 and it was one of the clear winners for the medical conference. That's because it reported positive results from two of its studies. The positive results were made possible through the use of the biotech's Tumor infil… read more...
These 27 Fortune 500 Dividend Stocks Made The Best Total Returns To Investors
via: SeekingAlpha at 2019-06-11 10:29:57:000
Actionable Conclusions (1-10): Brokers Predict 16.65% To 39.75% Net Gains To June 2020 Three of the ten top Fortune 500 Best Dividend Investments by yield were verified as being among the top ten gainers for the coming year based on analyst 1-year target prices. (They are tinted gray i… read more...
FDA Approves Two New Indications for Merck's KEYTRUDA® (pembrolizumab)
via: Business Wire at 2019-06-11 02:45:00:000
KEYTRUDA Now Approved for First-Line Treatment of Patients with Metastatic or with Unresectable, Recurrent Head and Neck Squamous Cell Carcinoma as Monotherapy for Patients Whose Tumors Express PD-L1 (CPS 1) or in Combination with Platinum and Fluorouracil (FU) Regardless of PD-L1 E… read more...
Zymeworks: Leader In Bispecifics Space Makes Substantial Headway
via: SeekingAlpha at 2019-06-11 02:07:59:000
Shares of Zymeworks ( ZYME ) have nearly doubled since I suggested that readers "buy the dip" in February 2018. In that article, I pointed out that a bet on the stock was not merely a wager on prospects for lead program ZW25, but also on its impressive platform technologies with several part… read more...
Merck to Acquire Tilos Therapeutics
via: Business Wire at 2019-06-10 02:45:00:000
Merck Gains Portfolio of Investigational Antibodies Modulating TGF Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that it has entered into a definitive agreement to acquire Tilos Therapeutics, a privately held biopharmaceutical company de… read more...
Dividend Challenger Highlights: Week Of June 9
via: SeekingAlpha at 2019-06-10 02:40:50:000
Introduction The Dividend Champions list is a monthly compilation of companies which have consistently increased their annual dividend payouts, and the latest edition may be found here . However, since this list is only produced once per month, the data in it can quickly get out of date. Fu… read more...
Buy Merck For Growth And Its Good Pipeline Of Breakthrough Drugs
via: SeekingAlpha at 2019-06-09 16:11:39:000
Merck ( MRK ) is a buy for the total return investor that also wants some income as the world economy grows. Merck is one of the largest drug companies in the world. MRK is a conservative investment since it is also a defensive company if the market turns down. Merck will be reviewed using T… read more...
Chewy IPO, Lululemon And Tesla On Tap (Stocks To Watch Podcast)
via: SeekingAlpha at 2019-06-09 03:30:00:000
Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks.. If you are interested in listening to Stocks To Watch to start your Sunday (you can r… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|---|---|---|---|---|---|---|---|
| 2019-09-13 | 2019-10-07 | 2019-09-16 | 2019-07-23 | 0.55 | No Change QoQ | |||
| 2019-06-14 | 2019-07-08 | 2019-06-17 | 2019-05-28 | 0.55 | No Change QoQ | |||
| 2019-03-14 | 2019-04-05 | 2019-03-15 | 2019-01-29 | 0.55 | No Change QoQ | |||
| 2018-12-14 | 2019-01-08 | 2018-12-17 | 2018-10-25 | 0.55 | Increase | |||
| 2018-09-14 | 2018-10-05 | 2018-09-17 | 2018-07-24 | 0.48 | No Change QoQ | |||
| 2018-06-14 | 2018-07-09 | 2018-06-15 | 2018-05-22 | 0.48 | No Change QoQ | |||
| 2018-03-14 | 2018-04-06 | 2018-03-15 | 2018-01-23 | 0.48 | No Change QoQ | |||
| 2017-12-14 | 2018-01-08 | 2017-12-15 | 2017-11-28 | 0.48 | Increase | |||
| 2017-09-14 | 2017-10-06 | 2017-09-15 | 2017-07-25 | 0.47 | No Change QoQ | |||
| 2017-06-13 | 2017-07-10 | 2017-06-15 | 2017-05-23 | 0.47 | No Change QoQ | |||
| 2017-03-13 | 2017-04-07 | 2017-03-15 | 2017-02-28 | 0.47 | No Change QoQ | |||
| 2016-12-13 | 2017-01-09 | 2016-12-15 | 2016-11-22 | 0.47 | Increase | |||
| 2016-09-13 | 2016-10-07 | 2016-09-15 | 2016-07-26 | 0.46 | No Change QoQ | |||
| 2016-06-13 | 2016-07-08 | 2016-06-15 | 2016-05-24 | 0.46 | No Change QoQ | |||
| 2016-03-11 | 2016-04-07 | 2016-03-15 | 2016-02-23 | 0.46 | No Change QoQ | |||
| 2015-12-11 | 2016-01-08 | 2015-12-15 | 2015-11-24 | 0.46 | Increase | |||
| 2015-09-11 | 2015-10-07 | 2015-09-15 | 2015-07-22 | 0.45 | No Change QoQ | |||
| 2015-06-11 | 2015-07-08 | 2015-06-15 | 2015-05-26 | 0.45 | No Change QoQ | |||
| 2015-03-12 | 2015-04-08 | 2015-03-16 | 2015-02-24 | 0.45 | No Change QoQ | |||
| 2014-12-11 | 2015-01-08 | 2014-12-15 | 2014-11-25 | 0.45 | Increase | |||
| 2019-12-13 | 2020-01-08 | 2019-12-16 | 2019-11-19 | 0.61 | Cash | |||
| 2020-03-13 | 2020-04-07 | 2020-03-16 | 2020-01-28 | 0.61 | Cash | |||
| 2020-06-12 | 2020-07-07 | 2020-06-15 | 2020-05-26 | 0.61 | Cash | |||
| 2020-09-14 | 2020-10-07 | 2020-09-15 | 2020-07-28 | 0.61 | Cash | |||
| 2020-12-14 | 2021-01-08 | 2020-12-15 | 2020-11-17 | 0.6499999761581421 | Cash | |||
| 2021-03-12 | 2021-04-07 | 2021-03-15 | 2021-01-26 | 0.65 | Cash | |||
| 2021-06-14 | 2021-07-07 | 2021-06-15 | 2021-05-25 | 0.65 | Cash | |||
| 2021-09-14 | 2021-10-07 | 2021-09-15 | 2021-07-27 | 0.65 | Cash | |||
| 2021-12-14 | 2022-01-07 | 2021-12-15 | 2021-11-30 | 0.69 | Cash | |||
| 2022-03-14 | 2022-04-07 | 2022-03-15 | 2022-01-25 | 0.69 | Cash | |||
| 2022-06-14 | 2022-07-08 | 2022-06-15 | 2022-05-24 | 0.69 | Cash | |||
| 2022-09-14 | 2022-10-07 | 2022-09-15 | 2022-07-26 | 0.69 | Cash | |||
| 2022-12-14 | 2023-01-09 | 2022-12-15 | 2022-11-29 | 0.73 | Cash | |||
| 2023-03-14 | 2023-04-10 | 2023-03-15 | 2023-01-24 | 0.73 | Cash | |||
| 2023-06-14 | 2023-07-10 | 2023-06-15 | 2023-05-23 | 0.73 | Cash | |||
| 2023-09-14 | 2023-10-06 | 2023-09-15 | 2023-07-25 | 0.73 | Cash | |||
| 2023-12-14 | 2024-01-08 | 2023-12-15 | 2023-11-28 | 0.77 | Cash | |||
| 2024-03-14 | 2024-04-05 | 2024-03-15 | 2024-01-23 | 0.77 | Cash |
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|